These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23612990)

  • 1. The CD4/CD8 lineages: central decisions and peripheral modifications for T lymphocytes.
    Tanaka H; Taniuchi I
    Curr Top Microbiol Immunol; 2014; 373():113-29. PubMed ID: 23612990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transcription factor ThPOK suppresses Runx3 and imposes CD4(+) lineage fate by inducing the SOCS suppressors of cytokine signaling.
    Luckey MA; Kimura MY; Waickman AT; Feigenbaum L; Singer A; Park JH
    Nat Immunol; 2014 Jul; 15(7):638-45. PubMed ID: 24880459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonistic interplay between ThPOK and Runx in lineage choice of thymocytes.
    Egawa T; Taniuchi I
    Blood Cells Mol Dis; 2009; 43(1):27-9. PubMed ID: 19375362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reciprocal control of G1-phase progression is required for Th-POK/Runx3-mediated CD4/8 thymocyte cell fate decision.
    Sato T; Chiba T; Ohno S; Sato C; Sugoh T; Miyashita K; Akatsuka H; Hozumi K; Okada Y; Iida Y; Akatsuka A; Agata Y; Chiba M; Kohu K; Satake M; Tanabe H; Saya H; Habu S
    J Immunol; 2012 Nov; 189(9):4426-36. PubMed ID: 23018457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2,3,7,8-Tetrachlorodibenzo-p-dioxin modulates the expression of cKrox and Runx3, transcription regulatory factors controlling the lineage commitment of CD4+CD8+ into CD4 and CD8 thymocytes, respectively.
    Gill BC; Jeon CH; Sung HN; Kim HL; Jin DW; Park JH
    Toxicol Lett; 2008 Aug; 180(3):189-95. PubMed ID: 18602973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Runx and ThPOK: a balancing act to regulate thymocyte lineage commitment.
    Egawa T
    J Cell Biochem; 2009 Aug; 107(6):1037-45. PubMed ID: 19479890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis.
    Woolf E; Xiao C; Fainaru O; Lotem J; Rosen D; Negreanu V; Bernstein Y; Goldenberg D; Brenner O; Berke G; Levanon D; Groner Y
    Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7731-6. PubMed ID: 12796513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The network of transcription factors that underlie the CD4 versus CD8 lineage decision.
    Naito T; Taniuchi I
    Int Immunol; 2010 Oct; 22(10):791-6. PubMed ID: 20732858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Priming of lineage-specifying genes by Bcl11b is required for lineage choice in post-selection thymocytes.
    Kojo S; Tanaka H; Endo TA; Muroi S; Liu Y; Seo W; Tenno M; Kakugawa K; Naoe Y; Nair K; Moro K; Katsuragi Y; Kanai A; Inaba T; Egawa T; Venkatesh B; Minoda A; Kominami R; Taniuchi I
    Nat Commun; 2017 Sep; 8(1):702. PubMed ID: 28951542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What Happens in the Thymus Does Not Stay in the Thymus: How T Cells Recycle the CD4+-CD8+ Lineage Commitment Transcriptional Circuitry To Control Their Function.
    Vacchio MS; Bosselut R
    J Immunol; 2016 Jun; 196(12):4848-56. PubMed ID: 27260768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thpok-independent repression of Runx3 by Gata3 during CD4+ T-cell differentiation in the thymus.
    Xiong Y; Castro E; Yagi R; Zhu J; Lesourne R; Love PE; Feigenbaum L; Bosselut R
    Eur J Immunol; 2013 Apr; 43(4):918-28. PubMed ID: 23310955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAZR and Runx Factors Synergistically Repress ThPOK during CD8+ T Cell Lineage Development.
    Sakaguchi S; Hainberger D; Tizian C; Tanaka H; Okuda T; Taniuchi I; Ellmeier W
    J Immunol; 2015 Sep; 195(6):2879-87. PubMed ID: 26254341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TCF-1 and LEF-1 act upstream of Th-POK to promote the CD4(+) T cell fate and interact with Runx3 to silence Cd4 in CD8(+) T cells.
    Steinke FC; Yu S; Zhou X; He B; Yang W; Zhou B; Kawamoto H; Zhu J; Tan K; Xue HH
    Nat Immunol; 2014 Jul; 15(7):646-656. PubMed ID: 24836425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular control of CD4(+) T cell lineage plasticity and integrity.
    Ellmeier W
    Int Immunopharmacol; 2015 Oct; 28(2):813-7. PubMed ID: 25864621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+/CD8+ double-positive T cells: more than just a developmental stage?
    Overgaard NH; Jung JW; Steptoe RJ; Wells JW
    J Leukoc Biol; 2015 Jan; 97(1):31-8. PubMed ID: 25360000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lineage re-commitment of CD4CD8αα intraepithelial lymphocytes in the gut.
    Park Y; Moon SJ; Lee SW
    BMB Rep; 2016 Jan; 49(1):11-7. PubMed ID: 26592937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Views on helper/cytotoxic lineage choice from a bottom-up approach.
    Taniuchi I
    Immunol Rev; 2016 May; 271(1):98-113. PubMed ID: 27088909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development.
    Taniuchi I; Osato M; Egawa T; Sunshine MJ; Bae SC; Komori T; Ito Y; Littman DR
    Cell; 2002 Nov; 111(5):621-33. PubMed ID: 12464175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Th-POK and Runx3 in T cell development in human thymoma.
    Tokunaga T; Hayashi A; Kadota Y; Shiono H; Inoue M; Sawabata N; Okumura M
    Autoimmunity; 2009; 42(8):653-60. PubMed ID: 19886737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional regulation in helper versus cytotoxic-lineage decision.
    Taniuchi I
    Curr Opin Immunol; 2009 Apr; 21(2):127-32. PubMed ID: 19361971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.